The aim of this study was to evaluate circulating Gal-3 levels in patients with CAD and to investigate possible correlations with coronary atherosclerotic disease severity and atherosclerotic involvement in non-coronary territories such as carotid, femoral, and radial. Here, LGALS3 is linked to coronary artery disorder.